INT336923

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.20
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0.69
Pain Relevance 0.38

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

pigmentation (Fig4) endosome (Fig4) cell death (Fig4)
Golgi apparatus (Fig4) endoplasmic reticulum (Fig4)
Anatomy Link Frequency
lungs 2
Fig4 (Mus musculus)
Pain Link Frequency Relevance Heat
anesthesia 6 92.84 High High
isoflurane 4 91.64 High High
imagery 10 88.20 High High
fibrosis 38 81.12 Quite High
Bioavailability 4 57.56 Quite High
Inflammation 36 52.24 Quite High
corticosteroid 2 16.60 Low Low
Inflammatory response 12 10.32 Low Low
cytokine 12 5.00 Very Low Very Low Very Low
alcohol 10 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pulmonary Disease 42 85.44 High High
Pseudomonas Infection 36 84.44 Quite High
Cystic Fibrosis 38 81.12 Quite High
Disease 12 59.12 Quite High
Asthma 4 57.28 Quite High
INFLAMMATION 46 52.24 Quite High
Lung Cancer 2 31.24 Quite Low
Hypersensitivity 2 30.40 Quite Low
Infection 2 12.24 Low Low
Obstructive Airway Disease 4 9.28 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We observed significant amount of PLGA-PEGPS341-NileRed particles in murine lungs by 24 hrs and observed its sustained release from days 1 to 11 given the short half-life of the nile red (Fig 4).
Localization (release) of Fig 4 in lungs
1) Confidence 0.20 Published 2010 Journal J Nanobiotechnology Section Body Doc Link PMC2954907 Disease Relevance 0 Pain Relevance 0.18
In addition, we have verified that intranasal delivery of fluorescently labeled PLGA-PEGNileRed particles to murine lungs provide sustained release from day 1-11 (Fig 4).
Localization (release) of Fig 4 in lungs
2) Confidence 0.17 Published 2010 Journal J Nanobiotechnology Section Body Doc Link PMC2954907 Disease Relevance 0.69 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox